AlphaFold predicted structure
DOHH · Q9BU89

Mean pLDDT
96.1/ 100
Very high
302 residues
Confidence breakdown
- Very high(≥ 90)91%
- Confident(70–90)7%
- Low(50–70)1%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
deoxyhypusine hydroxylase
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalSevere microcephaly
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalneurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment
complex neurodevelopmental disorder
neurodegenerative disease
neurodevelopmental disorder
prostate cancer
prostate carcinoma
Familial prostate cancer
metabolic dysfunction-associated steatohepatitis
glioblastoma
colitis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Deoxyhypusine hydroxylase
Catalyzes the hydroxylation of the N(6)-(4-aminobutyl)-L-lysine intermediate produced by deoxyhypusine synthase/DHPS on a critical lysine of the eukaryotic translation initiation factor 5A/eIF-5A. This is the second step of the post-translational modification of that lysine into an unusual amino acid residue named hypusine (PubMed:16371467, PubMed:16533814, PubMed:19706422). Hypusination is unique to mature eIF-5A factor and is essential for its function (By similarity)
DOHH · Q9BU89

Mean pLDDT
96.1/ 100
Very high
302 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0